ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 620,09
0,14%
Dow Jones
39 127,80
0,04%
DAX
18 220,55
0,31%
Brent Oil
84,825
0,42%
Bitcoin
60 791,36
-0,04%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) Actualités

VTYX Ventyx Biosciences Inc

2,32
0,00 (0,00%)
27 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ventyx Biosciences Inc VTYX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,32 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,32
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/6/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
05/6/202422:21EDGAR2Form 8-K - Current report
05/6/202422:01GLOBEVentyx Biosciences Announces Positive Preclinical Data for..
16/5/202422:05GLOBEVentyx Biosciences to Participate in Three Upcoming Investor..
16/5/202414:12EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEVentyx Biosciences Announces Appointment of Matthew Moore as..
09/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEVentyx Biosciences Reports First Quarter 2024 Financial..
02/5/202422:05GLOBEVentyx Biosciences to Report First Quarter 2024 Financial..
26/4/202411:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
19/4/202412:00PRNUSVentyx Biosciences, Inc. Securities Fraud Class Action..
16/4/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202411:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
09/4/202412:10PRNUSInvestors in Ventyx Biosciences, Inc. Should Contact The..
05/4/202411:45PRNUSInvestors who lost money on Ventyx Biosciences, Inc.(VTYX)..
29/3/202410:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
26/3/202410:45PRNUSVentyx Biosciences, Inc. Sued for Securities Law Violations..
11/3/202414:01EDGAR2Form 8-K - Current report
11/3/202412:00GLOBEVentyx Biosciences Reports Clinical Data for its NLRP3..
11/3/202410:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
08/3/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
07/3/202414:45EDGAR2Form 8-K - Current report
07/3/202414:00GLOBEVentyx Biosciences Announces $100 Million Private Placement..
07/3/202411:45PRNUSClass Action Filed Against Ventyx Biosciences, Inc. (VTYX)..
06/3/202414:00GLOBEVentyx Biosciences to Participate in Two Upcoming Investor..
04/3/202414:00GLOBEVentyx Biosciences to Host Virtual Investor Event on March..
27/2/202422:08EDGAR2Form 8-K - Current report
27/2/202422:01GLOBEVentyx Biosciences Reports Fourth Quarter and Full Year 2023..
22/2/202413:00GLOBEVentyx Biosciences to Present Results of the Phase 2 Trial..
13/2/202422:09EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
06/2/202422:05GLOBEVentyx Biosciences to Participate in the Oppenheimer 34th..
04/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202301:22EDGAR2Form 144 - Report of proposed sale of securities
21/12/202301:10EDGAR2Form 144 - Report of proposed sale of securities
19/12/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:30EDGAR2Form 8-K - Current report
22/11/202322:57EDGAR2Form 8-K - Current report
21/11/202322:05GLOBEVentyx Biosciences to Participate in the 35th Annual Piper..
10/11/202314:00GLOBEVentyx Biosciences to Participate in the Jefferies London..
09/11/202322:05EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEVentyx Biosciences Reports Third Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
VTYX
Ventyx Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés